Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The Gabelli Healthcare & Wellness Trust | GRX | Jan 10, 2025 | 9.55 | -1.24 |
The Gdl Fund | GDL | Jan 10, 2025 | 8.08 | -0.68 |
The Glimpse Group | VRAR | Jan 10, 2025 | 2.09 | -6.70 |
The Hackett Group | HCKT | Jan 10, 2025 | 28.98 | -2.29 |
The Hain Celestial Group | HAIN | Jan 10, 2025 | 4.94 | -8.18 |
The Hershey | HSY | Jan 10, 2025 | 158.20 | -2.48 |
The Herzfeld Caribbean Basin Fund | CUBA | Jan 10, 2025 | 2.35 | -0.15 |
The Honest Company | HNST | Jan 10, 2025 | 5.90 | -6.79 |
The Intergroup | INTG | Jan 10, 2025 | 13.96 | +1.01 |
The J.M Smucker Company | SJM | Jan 10, 2025 | 100.90 | -4.30 |
The Joint | JYNT | Jan 10, 2025 | 10.03 | -1.38 |
The Marygold Companies | MGLD | Jan 10, 2025 | 1.81 | -7.18 |
The ODP | ODP | Jan 10, 2025 | 22.31 | -0.18 |
The OLB Group | OLB | Jan 10, 2025 | 1.75 | -6.22 |
The Oncology Institute | TOI | Jan 10, 2025 | 0.30 | +0.94 |
The ONE Group Hospitality | STKS | Jan 10, 2025 | 2.84 | -1.39 |
The Pennant Group | PNTG | Jan 10, 2025 | 25.82 | -2.82 |
The Real Brokerage | REAX | Jan 10, 2025 | 4.26 | +1.43 |
The Real Estate Select Sector SPDR Fund | XLRE | Jan 10, 2025 | 39.18 | -2.42 |
The RealReal | REAL | Jan 10, 2025 | 8.73 | 0.00 |
The RMR Group A | RMR | Jan 10, 2025 | 19.34 | -0.46 |
The Shyft Group | SHYF | Jan 10, 2025 | 10.31 | -5.33 |
The Trade Desk A | TTD | Jan 10, 2025 | 118.80 | -2.24 |
The9 ADR | NCTY | Jan 10, 2025 | 14.80 | -1.99 |
TherapeuticsMD | TXMD | Jan 10, 2025 | 1.10 | -0.90 |
Theratechnologies | THTX | Jan 10, 2025 | 1.87 | -6.27 |
Theravance Biopharma | TBPH | Jan 10, 2025 | 8.78 | -2.98 |
Theriva Biologics | TOVX | Jan 10, 2025 | 1.45 | -1.36 |
Thermo Fisher Scientific | TMO | Jan 10, 2025 | 542.31 | -0.48 |
Thermon Group | THR | Jan 10, 2025 | 27.65 | -3.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.